Yvonne Greenstreet
CIK 1446125 · Chief Executive Officer · last filed 2026-03-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.20M
Companies
4
Total Filings
95
Lifetime Open-Market Net
-$95.41M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALNY | Chief Executive Officer | 96,712 | $246.11 | $23.80M | -$95.41M | 56 | 2026-03-06 |
| PCRX | Director | 13,247 | $26.47 | $350.6K | $0 | 9 | 2022-06-08 |
| MC | Director | 706 | $66.76 | $47.1K | $0 | 23 | 2018-11-16 |
| Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted | Director | — | — | — | $0 | 1 | 2008-09-24 |
Recent Filings · Page 3 of 10
95 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-20 | ALNY | Notice (144) | −15,000 | -$4.20M | EDGAR |
| 2024-08-02 | ALNY | Mixed | — | -$2.80M | EDGAR |
| 2024-08-01 | ALNY | Notice (144) | −15,148 | -$4.09M | EDGAR |
| 2024-07-12 | ALNY | Sell (S) | −7,093 | -$1.85M | EDGAR |
| 2024-07-11 | ALNY | Notice (144) | −7,093 | -$1.85M | EDGAR |
| 2024-06-26 | ALNY | Mixed | +8,652 | -$1.92M | EDGAR |
| 2024-03-05 | ALNY | Grant (A) | +23,754 | $0 | EDGAR |
| 2024-02-29 | ALNY | Mixed | +2,989 | -$455.4K | EDGAR |
| 2024-02-20 | ALNY | Mixed | +9,923 | -$1.04M | EDGAR |
| 2023-08-07 | ALNY | Mixed | +4,884 | -$754.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.